We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$285M
AUM Growth
+$33.9M
Cap. Flow
-$13.6M
Cap. Flow %
-4.76%
Top 10 Hldgs %
67.96%
Holding
105
New
6
Increased
8
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.84M
2
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.6M
3
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$890K
4
ZIMV
ZimVie
ZIMV
+$642K
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$515K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$7.16M
2
VKTX icon
Viking Therapeutics
VKTX
+$2.17M
3
LK
Luckin Coffee Inc. American Depositary Shares
LK
+$2.11M
4
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$1.25M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$876K

Sector Composition

Rank Sector Weight
1 Healthcare 30.38%
2 Materials 27.67%
3 Financials 18.32%
4 Communication Services 6.88%
5 Technology 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWR icon
76
Quanta Services
PWR
$93.1B
$52K 0.02%
176
– –
SSB icon
77
SouthState Bank Corp
SSB
$10.2B
$52K 0.02%
534
– –
DHR icon
78
Danaher
DHR
$138B
$50K 0.02%
180
– –
LIN icon
79
Linde
LIN
$234B
$33K 0.01%
70
– –
UNH icon
80
UnitedHealth
UNH
$379B
$33K 0.01%
57
– –
BX icon
81
Blackstone
BX
$106B
$32K 0.01%
210
– –
HD icon
82
Home Depot
HD
$335B
$32K 0.01%
80
– –
CMG icon
83
Chipotle Mexican Grill
CMG
$42.6B
$29K 0.01%
500
– –
GE icon
84
GE Aerospace
GE
$375B
$28K 0.01%
150
– –
TMO icon
85
Thermo Fisher Scientific
TMO
$208B
$28K 0.01%
45
– –
CRM icon
86
Salesforce
CRM
$142B
$21K 0.01%
77
– –
MGTX icon
87
MeiraGTx Holdings
MGTX
$1.14B
$20K 0.01%
+4,703
New +$20.3K
KD icon
88
Kyndryl
KD
$2.81B
$10K ﹤0.01%
428
– –
STWD icon
89
Starwood Property Trust
STWD
$6.15B
$8K ﹤0.01%
400
– –
GEHC icon
90
GE HealthCare
GEHC
$27.8B
$5K ﹤0.01%
50
– –
WAB icon
91
Wabtec
WAB
$50.8B
$1K ﹤0.01%
6
– –
BBIO icon
92
BridgeBio Pharma
BBIO
$16.5B
– –
-21,000
Closed -$532K
CAG icon
93
Conagra Brands
CAG
$7.29B
– –
-10,000
Closed -$284K
CC icon
94
Chemours
CC
$2.55B
– –
-240
Closed -$5K
CRNX icon
95
Crinetics Pharmaceuticals
CRNX
$8.87B
– –
-8,426
Closed -$377K
FNB icon
96
FNB Corp
FNB
$6.71B
– –
-8,905
Closed -$122K
KHC icon
97
Kraft Heinz
KHC
$31.1B
– –
-333
Closed -$11K
LGND icon
98
Ligand Pharmaceuticals
LGND
$5.96B
– –
-85,000
Closed -$7.16M
OVID icon
99
Ovid Therapeutics
OVID
$439M
– –
-20,000
Closed -$15K
VLY icon
100
Valley National Bancorp
VLY
$7.94B
– –
-3,200
Closed -$22K
1 2 3
4
5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2024 Portfolio in Review

As of Q3 2024, David M. Knott Jr held 105 positions worth $285M, up 14% from $251M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

David M. Knott Jr withdrew a net $13.6M in Q3 2024, closing 13 positions and reducing 23 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $7.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in BioMarin Pharmaceuticals worth $2.39M.

  • David M. Knott Jr's largest Q3 2024 buy was BioMarin Pharmaceuticals: 34,000 shares worth $2.39M.
  • David M. Knott Jr added most to Janus Henderson AAA CLO ETF in Q3 2024, an estimated $1.6M increase.
  • David M. Knott Jr's biggest Q3 2024 reduction was Viking Therapeutics, cutting an estimated $2.17M.
  • David M. Knott Jr fully exited Ligand Pharmaceuticals in Q3 2024, selling an estimated $7.16M.
  • David M. Knott Jr's ten largest holdings make up 68% of its $285M portfolio in Q3 2024.
  • David M. Knott Jr opened 6 new positions and closed 13 in Q3 2024.
  • David M. Knott Jr's portfolio value rose 14% quarter-over-quarter to $285M.

Based on David M. Knott Jr's 13F filing for Q3 2024, filed 13 Nov 2024.